• Filing Date: 2020-11-09
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 24,154 $ 1,075
Restricted cash and cash equivalents 573 461
Accounts receivable, net 966 776
Inventory 591 302
Notes receivable, current portion 255 0
Other current assets, net 361 175
Current assets of discontinued operations 3 7,441
Total current assets 26,903 10,230
LONG-TERM ASSETS    
Property and equipment, net 554 442
Right-of-use lease assets, net 276 283
Goodwill 6,336 6,336
Intangible assets, net 7,429 8,244
Investments in unconsolidated companies 75 0
Notes receivable, long-term 1,445 0
Long- term assets of discontinued operations 0 3,457
Total long-term assets 16,115 18,762
Total assets 43,018 28,992
CURRENT LIABILITIES    
Accounts payable and accrued expenses 3,834 3,678
Loans payable, current portion 370 0
Lease liability, short-term 232 148
Contract liabilities 1,234 749
Current liabilities of discontinued operations 114 5,757
Total current liabilities 5,784 10,332
LONG-TERM LIABILITIES    
Notes payable, long-term 976 20,409
Loan payable, long-term 504 0
Lease liability, long term 60 161
Contract liabilities, long term 936 775
Other long-term liabilities 10 10
Long term liabilities held for sale and discontinued operations 14 536
Total long-term liabilities 2,500 21,891
Total liabilities 8,284 32,223
Series A Cumulative Convertible Redeemable Preferred stock, $0.0001 par value, 505,000 shares authorized and 502,327 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 6,442 5,804
Commitment and Contingencies
STOCKHOLDERS' EQUITY (DEFICIT)    
Common stock, $0.0001 par value, 100,000,000 and 30,000,000 shares authorized, 32,911,854 and 21,595,653 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 3 2
Preferred stock, $0.0001 par value, 2,000,000 authorized, 505,000 shares designated as Series A and 240,861 shares designated as Series B as of September 30, 2020 and December 31, 2019, respectively 0 0
Series B Cumulative Convertible Preferred stock, $0.0001 par value, 240,861 shares authorized, issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 0 0
Additional paid-in capital 68,117 19,371
Accumulated deficit (39,828) (28,408)
Total stockholders' equity (deficit) 28,292 (9,035)
Total liabilities and stockholders' equity (deficit) $ 43,018 $ 28,992